Covid-19 roundup: NIH spot­lights blood thin­ners in its next big tri­al; All it took was a pan­dem­ic to get JPM out of SF

Af­ter im­mune mod­u­la­tors and an­ti­bod­ies, blood thin­ners are the next class of drugs to be put through a Phase III tri­al or­ga­nized un­der the NIH …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.